Weekly Gadgets

Latest Posts

Latest Tweets

Find Us on Facebook

Stay Connected


Covid-19 vaccines for kids going to be approved soon


The union minister for state and family welfare Praveen Pawar on Tuesday said that covid-19 vaccination for children is in progress. Drugs Controller General of India has not yet given the final approval to the vaccines. Bharat Biotech’s indigenous Covid-19 vaccine Covaxin should be considered in the list of emergency vaccines for children in the age group of two to 18 years told the expert group looking at vaccine approvals. 

The recommendation is a step further looking at the increasing chances of a third wave of infection. The Drugs Controller General of India is expected to give the final approval soon looking at the rising covid-19 situation. According to the people who are aware of the matter, the step is going to complete within days. 

Union minister of state for health and family welfare Bharati Pravin Pawar on Tuesday said that evaluation of Covid-19 vaccine for children is in progress. “The process is on and we don’t interfere in this matter. Will go ahead after discussions with experts,” the minister said.

ZvCoV-D by Zydus Cadila: 

The dose has not yet been included as the part of vaccine drive. It has been approved for use in age groups 12 and above. Indigenously developed and needle-free ZyCoV-D is the first vaccine that is taken into account for the age group of 12-18 years in the country. The vaccine has also received EUA from the drug regulator. 

Covaxin by Bharat Biotech:

The vaccination has been recommended for the age group of 2 and above. It has not yet been included as part of the vaccination drive. 

Corbevax by Biological E:

The following vaccine has been given a green signal for trials in children aged 5-18. Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council (BIRAC) have developed the vaccine.

Covovax by Serum Institute of India (SII):

The Indian version of the Novovax vaccine brought to India by the SII for children has been recommended for children in the age group of 2-18. The company chief Adar Poonawalla said that he expected the vaccine to be approved in January of February next year.

Continue Reading on The India Saga

Leave a Reply